Current Ratio in Pharmaceuticals & Healthcare
How to interpret and apply current ratio when analyzing pharmaceuticals & healthcare stocks in US (NYSE/Nasdaq) markets, with reference to international markets like India.
Quick Recap: What is Current Ratio?
The current ratio measures a company's ability to pay short-term obligations with its short-term assets, a basic test of financial health.
Current Ratio = Current Assets ÷ Current Liabilities
How Current Ratio Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical Current Ratio2.0-3.5x
General benchmark: 1.5-3.0 is healthy. Below 1.0 is a red flag. Banks are excluded.
Sector data last reviewed: 2026-04
Example Pharmaceuticals & Healthcare Companies to Analyze
US Market (NYSE / Nasdaq)
Indian Market (NSE / BSE)
Filter pharmaceuticals & healthcare stocks by current ratio and other metrics:
Key Takeaways
- Current Ratio in pharmaceuticals & healthcare should be compared against sector peers in the same market (US S&P 500 / Russell or Indian NSE / BSE), not the broad market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Cross-list peers across markets, large-cap US names often set the global benchmark, while Indian peers can trade at different multiples due to growth and liquidity differences.
- Always cross-check with other metrics. No single ratio tells the full story.